)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
CRISPR Therapeutics
CRISPR Therapeutics (CRSP) investor relations material
CRISPR Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary21 Apr, 2026
Executive summary
Annual General Meeting scheduled for June 4, 2026, with voting available online and in person.
Shareholders are asked to approve financial statements, compensation, board elections, and capital structure changes.
Voting matters and shareholder proposals
Approval of 2025 financial statements and appropriation of results.
Discharge of Board and Executive Committee members.
Re-election of all current Board members and Compensation Committee members.
Binding and advisory votes on compensation for Board and Executive Committee, including maximum amounts and equity.
Approval of an increase to the capital band and conditional share capital for bond conversions.
Approval of the 2026 Stock Option and Incentive Plan.
Re-election of independent voting rights representative and auditors.
Provision to transact any other business at the meeting.
Board of directors and corporate governance
All current Board members and Chairman are nominated for re-election.
Compensation Committee members are also up for re-election.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CRISPR Therapeutics
- Shareholders will vote on director re-elections, compensation, capital increases, and a new incentive plan.CRSP
Proxy filing21 Apr 2026 - Expanding pipeline and innovative gene editing position the company for major growth.CRSP25th Annual Needham Virtual Healthcare Conference13 Apr 2026
- Comprehensive proxy covers board elections, executive pay, capital increases, and new incentive plan.CRSPProxy filing2 Apr 2026
- Disease-focused strategy and pipeline advances drive growth across cardiovascular, autoimmune, and cell therapy.CRSPTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Allogeneic CAR-T zugo-cel shows promise in oncology and autoimmune, with global expansion plans.CRSPCiti’s 2026 Virtual Oncology Leadership Summit18 Feb 2026
- CASGEVY sales drove revenue growth, but higher R&D and collaboration costs increased net loss.CRSPQ4 202512 Feb 2026
- Pipeline advances in gene editing, delivery, and cell therapy drive growth across key disease areas.CRSPGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Rapid pipeline expansion and strong Casgevy launch drive innovation in gene editing and cell therapy.CRSPJefferies 2024 Global Healthcare Conference1 Feb 2026
- First CRISPR drug launch, robust CAR T pipeline, and key data readouts expected within a year.CRSPGuggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026
Next CRISPR Therapeutics earnings date
Q1 20267 May, 2026
CRISPR Therapeutics
Next CRISPR Therapeutics earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage